HSFX2
gene geneOn this page
Summary
HSFX2 (heat shock transcription factor family, X-linked 2, HGNC:32701) is a protein-coding gene on chromosome Xq28, encoding Heat shock transcription factor, X-linked (Q9UBD0).
Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific. Predicted to be involved in regulation of transcription by RNA polymerase II. Located in nucleus.
Source: NCBI Gene 100130086 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 3 total
- MANE Select transcript:
NM_001164415
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:32701 |
| Approved symbol | HSFX2 |
| Name | heat shock transcription factor family, X-linked 2 |
| Location | Xq28 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000268738 |
| Ensembl biotype | protein_coding |
| Entrez | 100130086 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000598963
RefSeq mRNA: 1 — MANE Select: NM_001164415
NM_001164415
CCDS: CCDS48179
Canonical transcript exons
ENST00000598963 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00003053324 | 149592512 | 149593299 |
| ENSE00003215793 | 149594137 | 149595314 |
Expression profiles
Bgee: expression breadth ubiquitous, 124 present calls, max score 66.42.
Top tissues by expression
132 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| superior frontal gyrus | UBERON:0002661 | 66.42 | gold quality |
| right uterine tube | UBERON:0001302 | 64.14 | gold quality |
| cerebellum | UBERON:0002037 | 63.44 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 63.32 | gold quality |
| cerebellar cortex | UBERON:0002129 | 63.31 | gold quality |
| granulocyte | CL:0000094 | 62.57 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 61.90 | gold quality |
| right lung | UBERON:0002167 | 60.97 | gold quality |
| right coronary artery | UBERON:0001625 | 60.65 | gold quality |
| endocervix | UBERON:0000458 | 60.32 | gold quality |
| right testis | UBERON:0004534 | 60.28 | gold quality |
| fallopian tube | UBERON:0003889 | 59.28 | gold quality |
| testis | UBERON:0000473 | 59.03 | gold quality |
| left testis | UBERON:0004533 | 58.25 | gold quality |
| ventricular zone | UBERON:0003053 | 58.24 | gold quality |
| left uterine tube | UBERON:0001303 | 57.65 | gold quality |
| ganglionic eminence | UBERON:0004023 | 57.38 | gold quality |
| right frontal lobe | UBERON:0002810 | 57.18 | gold quality |
| cortical plate | UBERON:0005343 | 56.97 | gold quality |
| right ovary | UBERON:0002118 | 56.51 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 56.33 | gold quality |
| ovary | UBERON:0000992 | 55.89 | gold quality |
| left ovary | UBERON:0002119 | 55.80 | gold quality |
| popliteal artery | UBERON:0002250 | 55.71 | gold quality |
| tibial artery | UBERON:0007610 | 55.52 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 55.50 | silver quality |
| frontal cortex | UBERON:0001870 | 55.25 | gold quality |
| uterine cervix | UBERON:0000002 | 54.51 | gold quality |
| colonic epithelium | UBERON:0000397 | 54.51 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 54.40 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.28 |
Regulation
Is transcription factor: no
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| drosophila_melanogaster | Hsf | FBGN0001222 |
| caenorhabditis_elegans | hsf-1 | WBGENE00002004 |
Paralogs (9): HSF2 (ENSG00000025156), HSF4 (ENSG00000102878), HSFY2 (ENSG00000169953), HSFX1 (ENSG00000171116), HSFY1 (ENSG00000172468), HSF5 (ENSG00000176160), HSF1 (ENSG00000185122), HSFX4 (ENSG00000283463), HSFX3 (ENSG00000283697)
Protein
Protein identifiers
Heat shock transcription factor, X-linked — Q9UBD0 (reviewed: Q9UBD0)
All UniProt accessions (2): A0A140VK21, Q9UBD0
UniProt curated annotations — full annotation on UniProt →
Subcellular location. Nucleus. Cytoplasm.
Tissue specificity. Testis-specific.
Similarity. Belongs to the HSF family.
RefSeq proteins (1): NP_001157887* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000232 | HSF_DNA-bd | Domain |
| IPR036388 | WH-like_DNA-bd_sf | Homologous_superfamily |
| IPR036390 | WH_DNA-bd_sf | Homologous_superfamily |
Pfam: PF00447
UniProt features (8 total): region of interest 3, compositionally biased region 2, chain 1, DNA-binding region 1, cross-link 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9UBD0-F1 | 56.38 | 0.15 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (1): 215
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 9 (showing top):
GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, chrXq28, ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, GOMF_DNA_BINDING_TRANSCRIPTION_FACTOR_ACTIVITY, GOMF_CIS_REGULATORY_REGION_SEQUENCE_SPECIFIC_DNA_BINDING, GOMF_RNA_POLYMERASE_II_TRANSCRIPTION_REGULATORY_REGION_SEQUENCE_SPECIFIC_DNA_BINDING, GSE6269_HEALTHY_VS_STAPH_AUREUS_INF_PBMC_DN, GOCC_CHROMATIN
GO Biological Process (2): regulation of DNA-templated transcription (GO:0006355), regulation of transcription by RNA polymerase II (GO:0006357)
GO Molecular Function (5): DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), sequence-specific DNA binding (GO:0043565), DNA binding (GO:0003677), DNA-binding transcription factor activity (GO:0003700), protein binding (GO:0005515)
GO Cellular Component (3): chromatin (GO:0000785), nucleus (GO:0005634), cytoplasm (GO:0005737)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| regulation of DNA-templated transcription | 2 |
| cellular anatomical structure | 2 |
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| transcription by RNA polymerase II | 1 |
| chromatin | 1 |
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 1 |
| DNA-binding transcription factor activity | 1 |
| regulation of transcription by RNA polymerase II | 1 |
| DNA binding | 1 |
| nucleic acid binding | 1 |
| transcription cis-regulatory region binding | 1 |
| transcription regulator activity | 1 |
| binding | 1 |
| chromosome | 1 |
| intracellular membrane-bounded organelle | 1 |
| intracellular anatomical structure | 1 |
Protein interactions and networks
STRING
512 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| HSFX2 | VCX3B | Q9H321 | 452 |
| HSFX2 | EOLA2 | Q96DE9 | 447 |
| HSFX2 | CXorf51A | A0A1B0GTR3 | 447 |
| HSFX2 | PDZD4 | Q76G19 | 447 |
| HSFX2 | VCX2 | Q9H322 | 418 |
| HSFX2 | ZNF41 | P51814 | 399 |
| HSFX2 | TMEM185A | Q8NFB2 | 398 |
| HSFX2 | VCX3A | Q9NNX9 | 377 |
| HSFX2 | TSPYL2 | Q9H2G4 | 374 |
| HSFX2 | SPANXN4 | Q5MJ08 | 369 |
| HSFX2 | SPANXN3 | Q5MJ09 | 355 |
| HSFX2 | ARSF | P54793 | 353 |
| HSFX2 | DNAL1 | Q4LDG9 | 348 |
| HSFX2 | HRC | P23327 | 347 |
| HSFX2 | SPANXN2 | Q5MJ10 | 324 |
| HSFX2 | EOLA1 | Q8TE69 | 324 |
IntAct
34 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| ATXN1 | HSFX1 | psi-mi:“MI:0915”(physical association) | 0.670 |
| MAL2 | HSFX1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| AGTRAP | HSFX1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP12-2 | HSFX1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SDR16C5 | HSFX1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| MTIF3 | HSFX1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| MICOS13 | HSFX1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SYP | HSFX1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| HSFX1 | CACFD1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| HSFX1 | NCS1 | psi-mi:“MI:0914”(association) | 0.350 |
| HSFX1 | VCAN | psi-mi:“MI:0914”(association) | 0.350 |
| HSFX1 | MAL2 | psi-mi:“MI:0915”(physical association) | 0.000 |
| HSFX1 | AGTRAP | psi-mi:“MI:0915”(physical association) | 0.000 |
| HSFX1 | KRTAP12-2 | psi-mi:“MI:0915”(physical association) | 0.000 |
| HSFX1 | MTIF3 | psi-mi:“MI:0915”(physical association) | 0.000 |
| HSFX1 | MICOS13 | psi-mi:“MI:0915”(physical association) | 0.000 |
| HSFX1 | SYP | psi-mi:“MI:0915”(physical association) | 0.000 |
| HSFX1 | SDR16C5 | psi-mi:“MI:0915”(physical association) | 0.000 |
| HSFX1 | CACFD1 | psi-mi:“MI:0915”(physical association) | 0.000 |
| HSFX1 | RBFOX1 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (33): HSFX1 (Two-hybrid), HSFX2 (Two-hybrid), HSFX1 (Two-hybrid), HSFX2 (Two-hybrid), HSFX1 (Two-hybrid), HSFX2 (Two-hybrid), HSFX1 (Two-hybrid), HSFX2 (Two-hybrid), HSFX1 (Two-hybrid), HSFX2 (Two-hybrid), C19orf70 (Two-hybrid), AGTRAP (Two-hybrid), KRTAP12-2 (Two-hybrid), HSFX2 (Two-hybrid), HSFX2 (Two-hybrid)
ESM2 similar proteins: A0A5F9ZHS7, B1ASB6, C9JSJ3, I7HJS4, O08686, O35426, O60393, O88286, P17861, P20428, P31357, Q05AH6, Q15583, Q1WG82, Q2M1V0, Q2MHN3, Q2YDG1, Q32LE6, Q3SZZ2, Q3TQ03, Q495C1, Q497K7, Q4R2Z8, Q5HZG9, Q5IS58, Q6ZN32, Q7Z572, Q80W88, Q8BHP2, Q8CGW9, Q8IX15, Q8IXT2, Q8IY92, Q8IZ20, Q8K3E9, Q8N1L9, Q8N365, Q8N7G0, Q8R1H8, Q96MN9
Diamond homologs: A0A1B0GTS1, A0A1B0GWH4, B7XIV9, C4V6H6, D0VYS2, G0SB31, G5EFT5, J9VHZ9, O14283, O49403, P10961, P22121, P22335, P22813, P38529, P38530, P38531, P38532, P38533, P41151, P41153, P41154, Q00613, Q02953, Q03933, Q08DJ8, Q10PR4, Q1HGE8, Q1PDN3, Q338B0, Q40152, Q4G112, Q5A4X5, Q5AQ33, Q5CZP2, Q5KMX8, Q5ND04, Q652B0, Q67TP9, Q6F388
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
3 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 1 |
| Likely benign | 2 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
297 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| X:149593296:CTAA:C | acceptor_gain | 0.9900 |
| X:149594131:CATTA:C | donor_loss | 0.9900 |
| X:149594132:ATTAC:A | donor_loss | 0.9900 |
| X:149594133:TTACC:T | donor_loss | 0.9900 |
| X:149594134:TA:T | donor_loss | 0.9900 |
| X:149594135:ACCT:A | donor_loss | 0.9900 |
| X:149593300:C:CC | acceptor_gain | 0.9800 |
| X:149593270:T:C | acceptor_gain | 0.9600 |
| X:149593297:TAA:T | acceptor_gain | 0.9600 |
| X:149593245:T:TA | acceptor_gain | 0.9500 |
| X:149594480:T:TA | donor_gain | 0.9400 |
| X:149593246:C:A | acceptor_gain | 0.9300 |
| X:149594157:G:A | donor_gain | 0.9300 |
| X:149593270:T:TC | acceptor_gain | 0.9200 |
| X:149593266:CT:C | acceptor_gain | 0.9000 |
| X:149594108:AACC:A | donor_gain | 0.9000 |
| X:149593266:CTCTT:C | acceptor_gain | 0.8800 |
| X:149593267:TCTTT:T | acceptor_gain | 0.8800 |
| X:149593268:C:G | acceptor_gain | 0.8800 |
| X:149593308:C:CT | acceptor_gain | 0.8700 |
| X:149593268:C:CC | acceptor_gain | 0.8400 |
| X:149593309:A:T | acceptor_gain | 0.8400 |
| X:149593314:T:C | acceptor_gain | 0.8300 |
| X:149594135:A:AC | donor_gain | 0.8300 |
| X:149594136:C:CC | donor_gain | 0.8300 |
| X:149593264:GTCT:G | acceptor_gain | 0.8100 |
| X:149593300:CT:C | acceptor_loss | 0.8100 |
| X:149593248:C:CT | acceptor_gain | 0.8000 |
| X:149593314:T:TC | acceptor_gain | 0.8000 |
| X:149593299:ACTAT:A | acceptor_gain | 0.7900 |
AlphaMissense
2777 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1157699406 (X:149596594 G>A), RS1157776314 (X:149592064 C>T), RS1159182780 (X:149597300 A>G), RS1159232756 (X:149596445 C>T), RS1159444761 (X:149592057 T>C), RS1160398581 (X:149594322 T>C), RS1161383318 (X:149597050 C>T), RS1161578401 (X:149596927 G>A), RS1163731267 (X:149594284 G>A), RS1164015388 (X:149592320 G>T), RS1165068942 (X:149594974 G>A), RS1167137785 (X:149594946 G>A), RS1168183243 (X:149596802 A>G), RS1169457360 (X:149596793 G>A), RS1169550655 (X:149592204 T>C)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
5 total (human), top 5 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| perfluorooctanoic acid | increases expression | 1 |
| Benzo(a)pyrene | decreases methylation | 1 |
| Diethylhexyl Phthalate | decreases expression | 1 |
| Smoke | decreases expression | 1 |
| Valproic Acid | increases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.